Covid 19 mrna Vaccines...Yes/No?

[unclefishstick]

When people post an article and are too afraid to post the link where it came from.................it pretty much sums up what they are posting is misleading.

some people collect stamps,other people like to use websites as mental kitty litter boxes,others build crazy sheds in their yards...some hobbies are just stranger than others

 

[Switcher56]

hard to straddle a fence AND shit without getting it all over you...LOL!

corrected that 4 U

 

[armedoldhippy]

corrected that 4 U

they look the same?

 

[trichrider]

When people post an article and are too afraid to post the link where it came from.................it pretty much sums up what they are posting is misleading.

who's afraid?
just trying to avoid your inevitable ad hominem. you do know how to google, no?

78% of Victoria Aussies hospitalized with COV are fully vaccinated, another17% took one dose
https://www.independentsentinel.com/...took-one-dose/

57 Top Scientists and Doctors Release Shocking Study on COVID Vaccines and Demand Immediate Stop to All Vaccinations

By Dr. Roxana Bruno, Dr. Peter McCullough, and et al.
Global Research, September 27, 2021
enVolve 8 May 2021

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
First published on May 8, 2021
***
A group of 57 leading scientists, doctors and policy experts has released a report calling in to question the safety and efficacy of the current COVID-19 vaccines and are now calling for an immediate end to all vaccine programs. We urge you to read and share this damning report.
There are two certainties regarding the global distribution of Covid-19 vaccines. The first is that governments and the vast majority of the mainstream media are pushing with all their might to get these experimental drugs into as many people as possible. The second is that those who are willing to face the scorn that comes with asking serious questions about vaccines are critical players in our ongoing effort to spread the truth.
You can read an advanced copy of this manuscript in preprint below. It has been prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe to be urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today.
-enVolve, May 8, 2021
*
Original Source: Authorea

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers
Abstract
Since the start of the COVID-19 outbreak, the race for testing new platforms designed to confer immunity against SARS-CoV-2, has been rampant and unprecedented, leading to emergency authorization of various vaccines. Despite progress on early multidrug therapy for COVID-19 patients, the current mandate is to immunize the world population as quickly as possible. The lack of thorough testing in animals prior to clinical trials, and authorization based on safety data generated during trials that lasted less than 3.5 months, raise questions regarding the safety of these vaccines. The recently identified role of SARS-CoV-2 glycoprotein Spike for inducing endothelial damage characteristic of COVID-19, even in absence of infection, is extremely relevant given that most of the authorized vaccines induce the production of Spike glycoprotein in the recipients. Given the high rate of occurrence of adverse effects, and the wide range of types of adverse effects that have been reported to date, as well as the potential for vaccine-driven disease enhancement, Th2-immunopathology, autoimmunity, and immune evasion, there is a need for a better understanding of the benefits and risks of mass vaccination, particularly in the groups that were excluded in the clinical trials. Despite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities. We appeal to the need for a pluralistic dialogue in the context of health policies, emphasizing critical questions that require urgent answers if we wish to avoid a global erosion of public confidence in science and public health.
Introduction
Since COVID-19 was declared a pandemic in March 2020, over 150 million cases and 3 million deaths have been reported worldwide. Despite progress on early ambulatory, multidrug-therapy for high-risk patients, resulting in 85% reductions in COVID-19 hospitalization and death [1], the current paradigm for control is mass-vaccination. While we recognize the effort involved in development, production and emergency authorization of SARS-CoV-2 vaccines, we are concerned that risks have been minimized or ignored by health organizations and government authorities, despite calls for caution [2-8].
Vaccines for other coronaviruses have never been approved for humans, and data generated in the development of coronavirus vaccines designed to elicit neutralizing antibodies show that they may worsen COVID-19 disease via antibody-dependent enhancement (ADE) and Th2 immunopathology, regardless of the vaccine platform and delivery method [9-11]. Vaccine-driven disease enhancement in animals vaccinated against SARS-CoV and MERS-CoV is known to occur following viral challenge, and has been attributed to immune complexes and Fc-mediated viral capture by macrophages, which augment T-cell activation and inflammation [11-13].
In March 2020, vaccine immunologists and coronavirus experts assessed SARS-CoV-2 vaccine risks based on SARS-CoV-vaccine trials in animal models. The expert group concluded that ADE and immunopathology were a real concern, but stated that their risk was insufficient to delay clinical trials, although continued monitoring would be necessary [14]. While there is no clear evidence of the occurrence of ADE and vaccine-related immunopathology in volunteers immunized with SARS-CoV-2 vaccines [15], safety trials to date have not specifically addressed these serious adverse effects (SAE). Given that the follow-up of volunteers did not exceed 2-3.5 months after the second dose [16-19], it is unlikely such SAE would have been observed. Despite92 errors in reporting, it cannot be ignored that even accounting for the number of vaccines administered, according to the US Vaccine Adverse Effect Reporting System (VAERS), the number of deaths per million vaccine doses administered has increased more than 10-fold. We believe there is an urgent need for open scientific dialogue on vaccine safety in the context of large-scale immunization. In this paper, we describe some of the risks of mass vaccination in the context of phase 3 trial exclusion criteria and discuss the SAE reported in national and regional adverse effect registration systems. We highlight unanswered questions and draw attention to the need for a more cautious approach to mass vaccination.
SARS-CoV-2 phase 3 trial exclusion criteria
With few exceptions, SARS-CoV-2 vaccine trials excluded the elderly [16-19], making it impossible to identify the occurrence of post-vaccination eosinophilia and enhanced inflammation in elderly people. Studies of SARS-CoV vaccines showed that immunized elderly mice were at particularly high risk of life-threatening Th2 immunopathology [9,20]. Despite this evidence and the extremely limited data on safety and efficacy of SARS-CoV-2 vaccines in the elderly, mass-vaccination campaigns have focused on this age group from the start. Most trials also excluded pregnant and lactating volunteers, as well as those with chronic and serious conditions such as tuberculosis, hepatitis C, autoimmunity, coagulopathies, cancer, and immune suppression [16-29], although these recipients are now being offered the vaccine under the premise of safety.
Another criterion for exclusion from nearly all trials was prior exposure to SARS-CoV-2. This is unfortunate as it denied the opportunity of obtaining extremely relevant information concerning post-vaccination ADE in people that already have anti-SARS-Cov-2 antibodies. To the best of our knowledge, ADE is not being monitored systematically for any age or medical condition group currently being administered the vaccine. Moreover, despite a substantial proportion of the population already having antibodies [21], tests to determine SARS-CoV-2-antibody status prior to administration of the vaccine are not conducted routinely.
Will serious adverse effects from the SARS-CoV-2 vaccines go unnoticed?
COVID-19 encompasses a wide clinical spectrum, ranging from very mild to severe pulmonary pathology and fatal multi-organ disease with inflammatory, cardiovascular, and blood coagulation dysregulation [22-24]. In this sense, cases of vaccine-related ADE or immunopathology would be clinically-indistinguishable from severe COVID-19 [25]. Furthermore, even in the absence of SARS-CoV-2 virus, Spike glycoprotein alone causes endothelial damage and hypertension in vitro and in vivo in Syrian hamsters by down-regulating angiotensin-converting enzyme 2 (ACE2) and impairing mitochondrial function [26]. Although these findings need to be confirmed in humans, the implications of this finding are staggering, as all vaccines authorized for emergency use are based on the delivery or induction of Spike glycoprotein synthesis. In the case of mRNA vaccines and adenovirus-vectorized vaccines, not a single study has examined the duration of Spike production in humans following vaccination. Under the cautionary principle, it is parsimonious to consider vaccine-induced Spike synthesis could cause clinical signs of severe COVID-19, and erroneously be counted as new cases of SARS-CoV-2 infections. If so, the true adverse effects of the current global vaccination strategy may never be recognized unless studies specifically examine this question. There is already non-causal evidence of temporary or sustained increases138 in COVID-19 deaths following vaccination in some countries (Fig. 1) and in light of Spike’s pathogenicity, these deaths must be studied in depth to determine whether they are related to vaccination.
Unanticipated adverse reactions to SARS-CoV-2 vaccines
Another critical issue to consider given the global scale of SARS-CoV-2 vaccination is autoimmunity. SARS-CoV-2 has numerous immunogenic proteins, and all but one of its immunogenic epitopes have similarities to human proteins [27]. These may act as a source of antigens, leading to autoimmunity [28]. While it is true that the same effects could be observed during natural infection with SARS-CoV-2, vaccination is intended for most of the world population, while it is estimated that only 10% of the world population has been infected by SARS-CoV-2, according to Dr. Michael Ryan, head of emergencies at the World Health Organization. We have been unable to find evidence that any of the currently authorized vaccines screened and excluded homologous immunogenic epitopes to avoid potential autoimmunity due to pathogenic priming.

WHO: No Guarantee COVID Vaccines Will Prevent People from Being Infected​

Some adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized ChAdOx1-nCov-19 and Janssen vaccinesin some countries. It has now been proposed that vaccination with ChAdOx1-nCov-19 can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia [29]. Unfortunately, the risk was overlooked when authorizing these vaccines, although adenovirus-induced thrombocytopenia has been known for more than a decade, and has been a consistent event with adenoviral vectors [30]. The risk of VITT would presumably be higher in those already at risk of blood clots, including women who use oral contraceptives [31], making it imperative for clinicians to advise their patients accordingly.
At the population level, there could also be vaccine-related impacts. SARS-CoV-2 is a fast-evolving RNA virus that has so far produced more than 40,000 variants [32,33] some of which affect the antigenic domain of Spike glycoprotein [34,35]. Given the high mutation rates, vaccine-induced synthesis of high levels of anti-SARS-CoV-2-Spike antibodies could theoretically lead to suboptimal responses against subsequent infections by other variants in vaccinated individuals [36], a phenomenon known as “original antigenic sin” [37] or antigenic priming [38]. It is unknown to what extent mutations that affect SARS-CoV-2 antigenicity will become fixed during viral evolution [39], but vaccines could plausibly act as selective forces driving variants with higher infectivity or transmissibility. Considering the high similarity between known SARS-CoV-2 variants, this scenario is unlikely [32,34] but if future variants were to differ more in key epitopes, the global vaccination strategy might have helped shape an even more dangerous virus. This risk has recently been brought to the attention of the WHO as an open letter [40].
Discussion
The risks outlined here are a major obstacle to continuing global SARS-CoV-2 vaccination. Evidence on the safety of all SARS-CoV-2 vaccines is needed before exposing more people to the184 risk of these experiments, since releasing a candidate vaccine without time to fully understand the resulting impact on health could lead to an exacerbation of the current global crisis [41]. Risk-stratification of vaccine recipients is essential. According to the UK government, people below 60 years of age have an extremely low risk of dying from COVID-191 187 . However, according to Eudravigillance, most of the serious adverse effects following SARS-CoV-2 vaccination occur in people aged 18-64. Of particular concern is the planned vaccination schedule for children aged 6 years and older in the United States and the UK. Dr. Anthony Fauci recently anticipated that teenagers across the country will be vaccinated in the autumn and younger children in early 2022, and the UK is awaiting trial results to commence vaccination of 11 million children under 18. There is a lack of scientific justification for subjecting healthy children to experimental vaccines, given that the Centers for Disease Control and Prevention estimates that they have a 99.997% survival rate if infected with SARS-CoV-2. Not only is COVID-19 irrelevant as a threat to this age group, but there is no reliable evidence to support vaccine efficacy or effectiveness in this population or to rule out harmful side effects of these experimental vaccines. In this sense, when physicians advise patients on the elective administration of COVID-19 vaccination, there is a great need to better understand the benefits and risk of administration, particularly in understudied groups.
In conclusion, in the context of the rushed emergency-use-authorization of SARS-CoV-2 vaccines, and the current gaps in our understanding of their safety, the following questions must be raised:

• Is it known whether cross-reactive antibodies from previous coronavirus infections or vaccine206 induced antibodies may influence the risk of unintended pathogenesis following vaccination with COVID-19?
• Has the specific risk of ADE, immunopathology, autoimmunity, and serious adverse reactions been clearly disclosed to vaccine recipients to meet the medical ethics standard of patient understanding for informed consent? If not, what are the reasons, and how could it be implemented?
• What is the rationale for administering the vaccine to every individual when the risk of dying from COVID-19 is not equal across age groups and clinical conditions and when the phase 3 trials excluded the elderly, children and frequent specific conditions?
• What are the legal rights of patients if they are harmed by a SARS-CoV-2 vaccine? Who will cover the costs of medical treatment? If claims were to be settled with public money, has the public been made aware that the vaccine manufacturers have been granted immunity, and their responsibility to compensate those harmed by the vaccine has been transferred to the tax-payers?

In the context of these concerns, we propose halting mass-vaccination and opening an urgent pluralistic, critical, and scientifically-based dialogue on SARS-CoV-2 vaccination among scientists, medical doctors, international health agencies, regulatory authorities, governments, and vaccine developers. This is the only way to bridge the current gap between scientific evidence and public health policy regarding the SARS-CoV-2 vaccines. We are convinced that humanity deserves a deeper understanding of the risks than what is currently touted as the official position. An open scientific dialogue is urgent and indispensable to avoid erosion of public confidence in science and public health and to ensure that the WHO and national health authorities protect the interests of humanity during the current pandemic. Returning public health policy to evidence-based medicine, relying on a careful evaluation of the relevant scientific research, is urgent. It is imperative to follow the science.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Sen. Ron Johnson Drops Truth Bomb on True Number of ‘Fully Vaccinated’ People Dying with Covid

by Kyle Becker a day ago updated about 22 hours ago

Senator Ron Johnson took to the Senate floor on Thursday to unveil some Covid facts that the mainstream media have been censoring to keep Americans from finding out the truth.


Johnson referred directly to public health figures from England, because health authorities in the United States are obfuscating the facts or misleading Americans with their Covid reports.

“Let’s look at some data,” Sen. Johnson said. “The type of data we are not getting from our healthcare agencies, so we have to look, unfortunately, to England and Israel, that are more transparent.”


“I will give you the highlights,” Johnson went on. “But I am showing that this is from Public Health England. This is one of their federal healthcare agencies. This is from their Technical Briefing number 23, dated September 17th, 2021.”


“It covers cases for about seven-and-a-half months,” he continued. “What the data shows for that seven-and-a-half month period in England, there were about 750,000 new Covid cases. About a little under 600,000 of those were Delta variant – about eighty percent.”
The number of deaths associated with those 600,000 Delta cases was 2,542,” Johnson added. “Which gives us a Case Fatality Ratio of about 0.4. Now, again, case fatality is higher than infection fatality because these are actually registered cases and there are all kinds of infections that never get registeredThis poll gives you

“So, to put this in context, an infection fatality rate for a bad flu season is slightly under 0.2,” he went on. “Half of this. Just to put things in perspective.”
“Now, President Biden – and this has been parroted by media and news media – said that what we are currently experiencing is a ‘pandemic of the unvaccinated’,” Johnson said. “They don’t really give us any data to back that up. They just proclaim, pronounce that 99 percent of people with Covid now are unvaccinated. But they don’t give us the data.”


“Well, we have data from England,” he went on. “And here’s the data. So, of the 600,000 cases in England, 43% were the unvaxxed, 27% were with the fully vaxxed, another 30% were with partially vaxxed, or just undetermined.”

“Here is another quote from President Biden,” he continued. “President Biden said, ‘if you’re vaccinated, you’re not going to be hospitalized. You’re not going to an ICU unit. You’re not going to die. You’re not going to get Covid, if you have these vaccinations’.”

“Well, maybe that’s true in the U.S., I kind of doubt it,” he said. “Because in England, of the 600,000 new cases of Delta, of the over 2,500 deaths, 63% of those deaths, 1,613 people, were the fully vaccinated. Twenty-eight percent were with the unvaxxed.”





A fact check of Public Health England’s technical briefing shows that he is right. Here is the information that was reported. The circled number cited by Sen. Johnson is in the category “>14 days post dose 2” which means “fully vaccinated” as it is commonly used:

“Now, this is information the American people have probably never heard,” he said. “This information, by conveying it, I will get attacked. I will be vilified. I will be censored. I will be suppressed.”

“So, that is one of the reasons I come to the floor of the Senate to reveal this information that the American people need to know,” he concluded.
https://trendingpolitics.com/sen-ron...rce=whatfinger

 

[h.h.]

who's afraid?
just trying to avoid your inevitable ad hominem. you do know how to google, no?

78% of Victoria Aussies hospitalized with COV are fully vaccinated, another17% took one dose
https://www.independentsentinel.com/...took-one-dose/

57 Top Scientists and Doctors Release Shocking Study on COVID Vaccines and Demand Immediate Stop to All Vaccinations

By Dr. Roxana Bruno, Dr. Peter McCullough, and et al.
Global Research, September 27, 2021
enVolve 8 May 2021

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
First published on May 8, 2021
***
A group of 57 leading scientists, doctors and policy experts has released a report calling in to question the safety and efficacy of the current COVID-19 vaccines and are now calling for an immediate end to all vaccine programs. We urge you to read and share this damning report.
There are two certainties regarding the global distribution of Covid-19 vaccines. The first is that governments and the vast majority of the mainstream media are pushing with all their might to get these experimental drugs into as many people as possible. The second is that those who are willing to face the scorn that comes with asking serious questions about vaccines are critical players in our ongoing effort to spread the truth.
You can read an advanced copy of this manuscript in preprint below. It has been prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe to be urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today.
-enVolve, May 8, 2021
*
Original Source: Authorea

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers
Abstract
Since the start of the COVID-19 outbreak, the race for testing new platforms designed to confer immunity against SARS-CoV-2, has been rampant and unprecedented, leading to emergency authorization of various vaccines. Despite progress on early multidrug therapy for COVID-19 patients, the current mandate is to immunize the world population as quickly as possible. The lack of thorough testing in animals prior to clinical trials, and authorization based on safety data generated during trials that lasted less than 3.5 months, raise questions regarding the safety of these vaccines. The recently identified role of SARS-CoV-2 glycoprotein Spike for inducing endothelial damage characteristic of COVID-19, even in absence of infection, is extremely relevant given that most of the authorized vaccines induce the production of Spike glycoprotein in the recipients. Given the high rate of occurrence of adverse effects, and the wide range of types of adverse effects that have been reported to date, as well as the potential for vaccine-driven disease enhancement, Th2-immunopathology, autoimmunity, and immune evasion, there is a need for a better understanding of the benefits and risks of mass vaccination, particularly in the groups that were excluded in the clinical trials. Despite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities. We appeal to the need for a pluralistic dialogue in the context of health policies, emphasizing critical questions that require urgent answers if we wish to avoid a global erosion of public confidence in science and public health.
Introduction
Since COVID-19 was declared a pandemic in March 2020, over 150 million cases and 3 million deaths have been reported worldwide. Despite progress on early ambulatory, multidrug-therapy for high-risk patients, resulting in 85% reductions in COVID-19 hospitalization and death [1], the current paradigm for control is mass-vaccination. While we recognize the effort involved in development, production and emergency authorization of SARS-CoV-2 vaccines, we are concerned that risks have been minimized or ignored by health organizations and government authorities, despite calls for caution [2-8].
Vaccines for other coronaviruses have never been approved for humans, and data generated in the development of coronavirus vaccines designed to elicit neutralizing antibodies show that they may worsen COVID-19 disease via antibody-dependent enhancement (ADE) and Th2 immunopathology, regardless of the vaccine platform and delivery method [9-11]. Vaccine-driven disease enhancement in animals vaccinated against SARS-CoV and MERS-CoV is known to occur following viral challenge, and has been attributed to immune complexes and Fc-mediated viral capture by macrophages, which augment T-cell activation and inflammation [11-13].
In March 2020, vaccine immunologists and coronavirus experts assessed SARS-CoV-2 vaccine risks based on SARS-CoV-vaccine trials in animal models. The expert group concluded that ADE and immunopathology were a real concern, but stated that their risk was insufficient to delay clinical trials, although continued monitoring would be necessary [14]. While there is no clear evidence of the occurrence of ADE and vaccine-related immunopathology in volunteers immunized with SARS-CoV-2 vaccines [15], safety trials to date have not specifically addressed these serious adverse effects (SAE). Given that the follow-up of volunteers did not exceed 2-3.5 months after the second dose [16-19], it is unlikely such SAE would have been observed. Despite92 errors in reporting, it cannot be ignored that even accounting for the number of vaccines administered, according to the US Vaccine Adverse Effect Reporting System (VAERS), the number of deaths per million vaccine doses administered has increased more than 10-fold. We believe there is an urgent need for open scientific dialogue on vaccine safety in the context of large-scale immunization. In this paper, we describe some of the risks of mass vaccination in the context of phase 3 trial exclusion criteria and discuss the SAE reported in national and regional adverse effect registration systems. We highlight unanswered questions and draw attention to the need for a more cautious approach to mass vaccination.
SARS-CoV-2 phase 3 trial exclusion criteria
With few exceptions, SARS-CoV-2 vaccine trials excluded the elderly [16-19], making it impossible to identify the occurrence of post-vaccination eosinophilia and enhanced inflammation in elderly people. Studies of SARS-CoV vaccines showed that immunized elderly mice were at particularly high risk of life-threatening Th2 immunopathology [9,20]. Despite this evidence and the extremely limited data on safety and efficacy of SARS-CoV-2 vaccines in the elderly, mass-vaccination campaigns have focused on this age group from the start. Most trials also excluded pregnant and lactating volunteers, as well as those with chronic and serious conditions such as tuberculosis, hepatitis C, autoimmunity, coagulopathies, cancer, and immune suppression [16-29], although these recipients are now being offered the vaccine under the premise of safety.
Another criterion for exclusion from nearly all trials was prior exposure to SARS-CoV-2. This is unfortunate as it denied the opportunity of obtaining extremely relevant information concerning post-vaccination ADE in people that already have anti-SARS-Cov-2 antibodies. To the best of our knowledge, ADE is not being monitored systematically for any age or medical condition group currently being administered the vaccine. Moreover, despite a substantial proportion of the population already having antibodies [21], tests to determine SARS-CoV-2-antibody status prior to administration of the vaccine are not conducted routinely.
Will serious adverse effects from the SARS-CoV-2 vaccines go unnoticed?
COVID-19 encompasses a wide clinical spectrum, ranging from very mild to severe pulmonary pathology and fatal multi-organ disease with inflammatory, cardiovascular, and blood coagulation dysregulation [22-24]. In this sense, cases of vaccine-related ADE or immunopathology would be clinically-indistinguishable from severe COVID-19 [25]. Furthermore, even in the absence of SARS-CoV-2 virus, Spike glycoprotein alone causes endothelial damage and hypertension in vitro and in vivo in Syrian hamsters by down-regulating angiotensin-converting enzyme 2 (ACE2) and impairing mitochondrial function [26]. Although these findings need to be confirmed in humans, the implications of this finding are staggering, as all vaccines authorized for emergency use are based on the delivery or induction of Spike glycoprotein synthesis. In the case of mRNA vaccines and adenovirus-vectorized vaccines, not a single study has examined the duration of Spike production in humans following vaccination. Under the cautionary principle, it is parsimonious to consider vaccine-induced Spike synthesis could cause clinical signs of severe COVID-19, and erroneously be counted as new cases of SARS-CoV-2 infections. If so, the true adverse effects of the current global vaccination strategy may never be recognized unless studies specifically examine this question. There is already non-causal evidence of temporary or sustained increases138 in COVID-19 deaths following vaccination in some countries (Fig. 1) and in light of Spike’s pathogenicity, these deaths must be studied in depth to determine whether they are related to vaccination.
Unanticipated adverse reactions to SARS-CoV-2 vaccines
Another critical issue to consider given the global scale of SARS-CoV-2 vaccination is autoimmunity. SARS-CoV-2 has numerous immunogenic proteins, and all but one of its immunogenic epitopes have similarities to human proteins [27]. These may act as a source of antigens, leading to autoimmunity [28]. While it is true that the same effects could be observed during natural infection with SARS-CoV-2, vaccination is intended for most of the world population, while it is estimated that only 10% of the world population has been infected by SARS-CoV-2, according to Dr. Michael Ryan, head of emergencies at the World Health Organization. We have been unable to find evidence that any of the currently authorized vaccines screened and excluded homologous immunogenic epitopes to avoid potential autoimmunity due to pathogenic priming.

WHO: No Guarantee COVID Vaccines Will Prevent People from Being Infected​

Some adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized ChAdOx1-nCov-19 and Janssen vaccinesin some countries. It has now been proposed that vaccination with ChAdOx1-nCov-19 can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia [29]. Unfortunately, the risk was overlooked when authorizing these vaccines, although adenovirus-induced thrombocytopenia has been known for more than a decade, and has been a consistent event with adenoviral vectors [30]. The risk of VITT would presumably be higher in those already at risk of blood clots, including women who use oral contraceptives [31], making it imperative for clinicians to advise their patients accordingly.
At the population level, there could also be vaccine-related impacts. SARS-CoV-2 is a fast-evolving RNA virus that has so far produced more than 40,000 variants [32,33] some of which affect the antigenic domain of Spike glycoprotein [34,35]. Given the high mutation rates, vaccine-induced synthesis of high levels of anti-SARS-CoV-2-Spike antibodies could theoretically lead to suboptimal responses against subsequent infections by other variants in vaccinated individuals [36], a phenomenon known as “original antigenic sin” [37] or antigenic priming [38]. It is unknown to what extent mutations that affect SARS-CoV-2 antigenicity will become fixed during viral evolution [39], but vaccines could plausibly act as selective forces driving variants with higher infectivity or transmissibility. Considering the high similarity between known SARS-CoV-2 variants, this scenario is unlikely [32,34] but if future variants were to differ more in key epitopes, the global vaccination strategy might have helped shape an even more dangerous virus. This risk has recently been brought to the attention of the WHO as an open letter [40].
Discussion
The risks outlined here are a major obstacle to continuing global SARS-CoV-2 vaccination. Evidence on the safety of all SARS-CoV-2 vaccines is needed before exposing more people to the184 risk of these experiments, since releasing a candidate vaccine without time to fully understand the resulting impact on health could lead to an exacerbation of the current global crisis [41]. Risk-stratification of vaccine recipients is essential. According to the UK government, people below 60 years of age have an extremely low risk of dying from COVID-191 187 . However, according to Eudravigillance, most of the serious adverse effects following SARS-CoV-2 vaccination occur in people aged 18-64. Of particular concern is the planned vaccination schedule for children aged 6 years and older in the United States and the UK. Dr. Anthony Fauci recently anticipated that teenagers across the country will be vaccinated in the autumn and younger children in early 2022, and the UK is awaiting trial results to commence vaccination of 11 million children under 18. There is a lack of scientific justification for subjecting healthy children to experimental vaccines, given that the Centers for Disease Control and Prevention estimates that they have a 99.997% survival rate if infected with SARS-CoV-2. Not only is COVID-19 irrelevant as a threat to this age group, but there is no reliable evidence to support vaccine efficacy or effectiveness in this population or to rule out harmful side effects of these experimental vaccines. In this sense, when physicians advise patients on the elective administration of COVID-19 vaccination, there is a great need to better understand the benefits and risk of administration, particularly in understudied groups.
In conclusion, in the context of the rushed emergency-use-authorization of SARS-CoV-2 vaccines, and the current gaps in our understanding of their safety, the following questions must be raised:

• Is it known whether cross-reactive antibodies from previous coronavirus infections or vaccine206 induced antibodies may influence the risk of unintended pathogenesis following vaccination with COVID-19?
• Has the specific risk of ADE, immunopathology, autoimmunity, and serious adverse reactions been clearly disclosed to vaccine recipients to meet the medical ethics standard of patient understanding for informed consent? If not, what are the reasons, and how could it be implemented?
• What is the rationale for administering the vaccine to every individual when the risk of dying from COVID-19 is not equal across age groups and clinical conditions and when the phase 3 trials excluded the elderly, children and frequent specific conditions?
• What are the legal rights of patients if they are harmed by a SARS-CoV-2 vaccine? Who will cover the costs of medical treatment? If claims were to be settled with public money, has the public been made aware that the vaccine manufacturers have been granted immunity, and their responsibility to compensate those harmed by the vaccine has been transferred to the tax-payers?

In the context of these concerns, we propose halting mass-vaccination and opening an urgent pluralistic, critical, and scientifically-based dialogue on SARS-CoV-2 vaccination among scientists, medical doctors, international health agencies, regulatory authorities, governments, and vaccine developers. This is the only way to bridge the current gap between scientific evidence and public health policy regarding the SARS-CoV-2 vaccines. We are convinced that humanity deserves a deeper understanding of the risks than what is currently touted as the official position. An open scientific dialogue is urgent and indispensable to avoid erosion of public confidence in science and public health and to ensure that the WHO and national health authorities protect the interests of humanity during the current pandemic. Returning public health policy to evidence-based medicine, relying on a careful evaluation of the relevant scientific research, is urgent. It is imperative to follow the science.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Sen. Ron Johnson Drops Truth Bomb on True Number of ‘Fully Vaccinated’ People Dying with Covid

by Kyle Becker a day ago updated about 22 hours ago

Senator Ron Johnson took to the Senate floor on Thursday to unveil some Covid facts that the mainstream media have been censoring to keep Americans from finding out the truth.


Johnson referred directly to public health figures from England, because health authorities in the United States are obfuscating the facts or misleading Americans with their Covid reports.

“Let’s look at some data,” Sen. Johnson said. “The type of data we are not getting from our healthcare agencies, so we have to look, unfortunately, to England and Israel, that are more transparent.”


“I will give you the highlights,” Johnson went on. “But I am showing that this is from Public Health England. This is one of their federal healthcare agencies. This is from their Technical Briefing number 23, dated September 17th, 2021.”


“It covers cases for about seven-and-a-half months,” he continued. “What the data shows for that seven-and-a-half month period in England, there were about 750,000 new Covid cases. About a little under 600,000 of those were Delta variant – about eighty percent.”
The number of deaths associated with those 600,000 Delta cases was 2,542,” Johnson added. “Which gives us a Case Fatality Ratio of about 0.4. Now, again, case fatality is higher than infection fatality because these are actually registered cases and there are all kinds of infections that never get registeredThis poll gives you

“So, to put this in context, an infection fatality rate for a bad flu season is slightly under 0.2,” he went on. “Half of this. Just to put things in perspective.”
“Now, President Biden – and this has been parroted by media and news media – said that what we are currently experiencing is a ‘pandemic of the unvaccinated’,” Johnson said. “They don’t really give us any data to back that up. They just proclaim, pronounce that 99 percent of people with Covid now are unvaccinated. But they don’t give us the data.”


“Well, we have data from England,” he went on. “And here’s the data. So, of the 600,000 cases in England, 43% were the unvaxxed, 27% were with the fully vaxxed, another 30% were with partially vaxxed, or just undetermined.”

“Here is another quote from President Biden,” he continued. “President Biden said, ‘if you’re vaccinated, you’re not going to be hospitalized. You’re not going to an ICU unit. You’re not going to die. You’re not going to get Covid, if you have these vaccinations’.”

“Well, maybe that’s true in the U.S., I kind of doubt it,” he said. “Because in England, of the 600,000 new cases of Delta, of the over 2,500 deaths, 63% of those deaths, 1,613 people, were the fully vaccinated. Twenty-eight percent were with the unvaxxed.”





A fact check of Public Health England’s technical briefing shows that he is right. Here is the information that was reported. The circled number cited by Sen. Johnson is in the category “>14 days post dose 2” which means “fully vaccinated” as it is commonly used:

“Now, this is information the American people have probably never heard,” he said. “This information, by conveying it, I will get attacked. I will be vilified. I will be censored. I will be suppressed.”

“So, that is one of the reasons I come to the floor of the Senate to reveal this information that the American people need to know,” he concluded.
https://trendingpolitics.com/sen-ron...rce=whatfinger

That’s a globalization “watch” site. Whatever the fuck that is.

 

[Chi13]

Vic. Health Minister Martin Foley's vaccination gaffe fuels misinformation around the globe

RMIT ABC Fact Check

Posted Fri 1 Oct 2021 at 8:04amFriday 1 Oct 2021 at 8:04am, updated Fri 1 Oct 2021
CoronaCheck is RMIT ABC Fact Check's weekly email newsletter dedicated to fighting the misinformation infodemic surrounding the coronavirus outbreak.

CoronaCheck this week sets the record straight on vaccination rates among Victorians hospitalised with COVID-19 after a gaffe by the state's Health Minister, Martin Foley.

We also debunk claims that a protester in Melbourne died as a result of rubber bullets deployed by police, and bring you the verdict on a viral vaccination advertising campaign.
Anti-vaxxers revel in slip up from Vic. Health Minister

A slip of the tongue by the Victorian Health Minister has provided fodder for anti-vax activists who have shared footage of Martin Foley wrongly suggesting that 95 per cent of hospitalised COVID-19 patients were partially or fully vaccinated.

"Of the people who were in hospital yesterday, 78 per cent were vaccinated, and 17 were partially vaccinated," Mr Foley said during Tuesday's COVID-19 press briefing.
YOUTUBEABC News: "IN FULL: Health Minister Martin Foley provides Victoria's COVID-19 update | ABC News"
On Twitter, videos of Mr Foley's statement have been viewed at least half a million times.

"So 5% are un-vaxxed? Wow," wrote one Twitter user. "These numbers are the opposite of what we've [been] told will occur."

A spokeswoman for Mr Foley confirmed to Fact Check, however, that 78 per cent of those in hospital were unvaccinated, while 17 per cent had received just one dose. That means a mere 5 per cent of hospitalised COVID-19 patients in Victoria were double-jabbed.

His incorrect statement, meanwhile, has spread globally, with a US-based conservative website reporting that the "truth [was] being ignored" and that "95 per cent of the COVID patients in Victoria hospitals are vaccinated".
CoronaCheck #76

"What good are the vaccinations if 78% of those occupying the hospital are fully vaccinated?" posed the article, which was shared more than 400 times on Facebook and reached more than 500,000 Twitter users.

Fact Check reported on a similar gaffe back in July when the director of health protection at NSW Health, Jeremy McAnulty, announced that "all but one" of more than 40 COVID-19 patients in intensive care had been vaccinated.

Dr McAnulty corrected himself just minutes later (in fact, all but one were unvaccinated), but video of his original statement was shared widely regardless.
https://www.abc.net.au/news/2021-10-...affe/100504420

 

[mexcurandero420]

Former Australian MP Clive Palmer said at a press conference last month that Berejiklian has received "tens of millions" from AstraZeneca and Pfizer to vaccinate as many people as possible against corona.

It's all about $$$$$

 

[h.h.]

Former Australian MP Clive Palmer said at a press conference last month that Berejiklian has received "tens of millions" from AstraZeneca and Pfizer to vaccinate as many people as possible against corona.

It's all about $$$$$

Shame on the drug companies for giving money.

 

[mexcurandero420]

Shame on the drug companies for giving money.

That is what they always do, buying politicians so they can sell their products.Marketing is their biggest expense and research their smallest.

 

[troutman]

Former Australian MP Clive Palmer said at a press conference last month that Berejiklian has received "tens of millions" from AstraZeneca and Pfizer to vaccinate as many people as possible against corona.

It's all about $$$$$

Sadly, the sheep won't hear anything and keep bending over.

 

[entropical]

Former Australian MP Clive Palmer said at a press conference last month that Berejiklian has received "tens of millions" from AstraZeneca and Pfizer to vaccinate as many people as possible against corona.

It's all about $$$$$

Watched it in full, thanks for sharing!

 

[h.h.]

Sadly, the sheep won't hear anything and keep bending over.

Got a video or do you watch from the bushes?

 

[trichrider]

https://www.youtube.com/watch?v=HkLVnvN-Sb8
News Roundup | U.S. Poison Control Ivermectin Data Analyzed by TrialSite – Some Surprises

 

[trichrider]

J&J Vaccine Possibly Linked To Two More Serious Health Conditions, EU Regulator Finds


by Tyler Durden
Sunday, Oct 03, 2021 - 08:10 AM

Authored by Ivan Pentchoukov via The Epoch Times,
The European Union’s drug regulator on Oct. 1 recommended updating the label for Johnson & Johnson’s COVID-19 vaccine with warnings for two more serious health conditions likely linked with the vaccine.

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded that the use of the J&J vaccine is possibly linked with vein clotting and an immune condition that causes the immune system to attack blood platelets.

“The PRAC has concluded that there is a possible link to rare cases of venous thromboembolism (VTE) with COVID-19 Vaccine Janssen,” the committee meeting highlights stated.​

Venous thromboembolism “is a condition in which a blood clot forms in a deep vein, usually in a leg, arm, or groin, and may travel to the lungs causing a blockage of the blood supply, with possible life-threatening consequences,” the committee said.
Janssen, a J&J company, did not respond to a request for comment.
After reviewing new evidence, PRAC concluded that there is a “reasonable possibility” that the clotting condition is linked with vaccination using the J&J vaccine. The committee recommended listing venous thromboembolism as a rare side effect in the product information for the J&J vaccine.
The committee also found that the use of the J&J and the AstraZeneca vaccines is linked to an immune condition that causes the body’s immune system to target healthy platelets needed for normal blood clotting.

“Very low levels of blood platelets can be associated with bleeding, and have serious health consequences,” the committee said.​

PRAC recommended listing the immune condition as an “adverse reaction with an unknown frequency” for both the J&J and the AstraZeneca vaccines.
The regulator agreed to send warning statements directly to health care practitioners regarding both the clotting and the immune condition.
The communications about the immune thrombocytopenia (ITP) mentions that cases of the condition have been reported in the first four weeks after vaccination and “included serious cases with very low platelet counts.”

“If an individual has a history of ITP, healthcare professionals should consider the risk of developing low platelet levels prior to administering the vaccine. In individuals with a history of ITP, it is recommended to monitor platelet levels following vaccination with COVID-19 Vaccine Janssen,” the direct communication to doctors stated.​

The message to doctors regarding venous thromboembolism (VTE) noted that instances of the condition were rare, but that the risk of the condition should be considered for those with increased risk factors for blood clots. The message also noted that patients presenting with one of the two conditions should be checked for the other.

“This is important, to assess a potential diagnosis of thrombosis with thrombocytopenia syndrome (TTS), which requires specialized clinical management,” the communication said.
https://www.zerohedge.com/covid-19/...-serious-health-conditions-eu-regulator-finds​

The U.S. Food and Drug Administration (FDA) authorized the J&J vaccine for emergency use on Feb. 27, 2021.
Less than two months later, on April 23, the FDA amended the authorization to include information “about a very rare and serious type of blood clot in people who receive the vaccine.” The clotting condition in that case was separate from the one flagged by the European regulator on Oct. 1.
The FDA did not respond to a request for comment.

 

[unclefishstick]

so,this tyler durden is some sort of nom de plume for a conspiracy driven nonsense site...not what you would call a trustworthy source of info....try again

http://www.financemagnates.com/148484-revision-v1/

 

[entropical]

so,this tyler durden is some sort of nom de plume for a conspiracy driven nonsense site...not what you would call a trustworthy source of info....try again

http://www.financemagnates.com/148484-revision-v1/

Ad-hominem is not an argument, it is a fallacy.

https://www.ema.europa.eu/en/news/m...ssessment-committee-prac-27-30-september-2021

 

[unclefishstick]

Ad-hominem is not an argument, it is a fallacy.

https://www.ema.europa.eu/en/news/m...ssessment-committee-prac-27-30-september-2021

ad ho·mi·nem

/ˌad ˈhämənəm/




adjective
adjective: ad hominem

• (of an argument or reaction) directed against a person rather than the position they are maintaining.
  "vicious ad hominem attacks"

adverb
adverb: ad hominem

• 1.
  in a way that is directed against a person rather than the position they are maintaining.
  "these points come from some of our best information sources, who realize they'll be attacked ad hominem"
• 2.
  in a way that relates to or is associated with a particular person.
  "the office was created ad hominem for Fenton"

 

[entropical]

ad hominem

So, do you trust in the European Union?

 

[unclefishstick]

So, do you trust in the European Union?

not if they still let belgians in

 

[entropical]

not if they still let belgians in

Belgians?